84 results
S-3
SILO
SILO Pharma Inc
23 Jan 24
Shelf registration
5:01pm
of directors constituting our Board of Directors may be set only by resolution of the majority of the incumbent directors.
Special Meeting … .
The holders of a majority in principal amount of the outstanding debt securities of an affected series may waive any default or event of default
S-3
EX-4.2
SILO
SILO Pharma Inc
23 Jan 24
Shelf registration
5:01pm
the meanings as set forth in Section 2.05.
“Subsidiary” means, with respect to any Person, (i) any corporation at least a majority of whose outstanding … of its Subsidiaries, (ii) any general partnership, joint venture or similar entity, at least a majority of whose outstanding partnership or similar
S-3
EX-4.3
SILO
SILO Pharma Inc
23 Jan 24
Shelf registration
5:01pm
, with respect to any Person, (i) any corporation at least a majority of whose outstanding Voting Stock shall at the time be owned, directly or indirectly … venture or similar entity, at least a majority of whose outstanding partnership or similar interests shall at the time be owned by such Person, or by one
8-K12B
EX-2.1
kt27oggc4lmff7
20 Dec 23
Notification of registration of securities
4:58pm
8-K12B
EX-3.4
4nk92xyc08
20 Dec 23
Notification of registration of securities
4:58pm
8-K12B
EX-4.1
9bx6u
20 Dec 23
Notification of registration of securities
4:58pm
8-K
EX-10.2
7js3n40c791x78ocn6
18 Oct 22
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-1.1
qur4mwy ruqfi
30 Sep 22
Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock
8:45am
8-K
EX-4.1
4exp21tmy
30 Sep 22
Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock
8:45am
424B4
13b63lrtnb9
28 Sep 22
Prospectus supplement with pricing info
4:34pm